FDA adverse event reports of statin-associated rhabdomyolysis.

被引:0
|
作者
Ardati, A [1 ]
Knapp, D [1 ]
Lurie, P [1 ]
Wolfe, S [1 ]
机构
[1] Publ Citizen, Washington, DC USA
关键词
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
引用
收藏
页码:226 / 226
页数:1
相关论文
共 50 条
  • [21] FDA Reports of Alopecia as an Adverse Event to Isotretinoin
    Tkachenko, Elizabeth
    Singer, Sean B.
    Sharma, Priyank
    Barbieri, John
    Mostaghimi, Arash
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2019, 23 (04) : 451 - 452
  • [22] Incidence of Statin-Associated Adverse Events in Kidney Transplant Recipients
    Bae, Sunjae
    Ahn, JiYoon B.
    Joseph, Corey
    Whisler, Ryan
    Schnitzler, Mark A.
    Lentine, Krista L.
    Kadosh, Bernard S.
    Segev, Dorry L.
    McAdams-DeMarco, Mara A.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2023, 18 (05): : 626 - 633
  • [23] What to Believe and Do About Statin-Associated Adverse Effects
    Thompson, Paul D.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (19): : 1969 - 1970
  • [24] Statin-associated adverse effects beyond muscle and liver toxicity
    Kiortsis, D. N.
    Filippatos, T. D.
    Mikhailidis, D. P.
    Elisaf, M. S.
    Liberopoulos, E. N.
    ATHEROSCLEROSIS, 2007, 195 (01) : 7 - 16
  • [25] Evaluation of atypical antipsychotics associated rhabdomyolysis using the FDA adverse event reporting system database
    Yin, Yi
    Jiang, Jie
    Jin, Youpeng
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [26] The Association Between Statin Drugs and Rhabdomyolysis: An Analysis of FDA Adverse Event Reporting System (FAERS) Data and Transcriptomic Profiles
    Morris, Robert
    Bu, Kun
    Han, Weiru
    Wood, Savanah
    Velez, Paola M. Hernandez
    Ward, Jacob
    Crescitelli, Ariana
    Martin, Madison
    Cheng, Feng
    GENES, 2025, 16 (03)
  • [27] Statin-associated neuromyotoxicity
    Baker, SK
    Tarnopolsky, MA
    DRUGS OF TODAY, 2005, 41 (04) : 267 - 293
  • [28] Statin-associated myopathy
    Hamilton-Craig, I
    MEDICAL JOURNAL OF AUSTRALIA, 2001, 175 (09) : 486 - +
  • [29] Ovary and uterus related adverse events associated with statin use: an analysis of the FDA Adverse Event Reporting System
    Xue-feng Jiao
    Hai-long Li
    Xue-yan Jiao
    Yuan-chao Guo
    Chuan Zhang
    Chun-song Yang
    Li-nan Zeng
    Zhen-yan Bo
    Zhe Chen
    Hai-bo Song
    Ling-li Zhang
    Scientific Reports, 10
  • [30] Ovary and uterus related adverse events associated with statin use: an analysis of the FDA Adverse Event Reporting System
    Jiao, Xue-feng
    Li, Hai-long
    Jiao, Xue-yan
    Guo, Yuan-chao
    Zhang, Chuan
    Yang, Chun-song
    Zeng, Li-nan
    Bo, Zhen-yan
    Chen, Zhe
    Song, Hai-bo
    Zhang, Ling-li
    SCIENTIFIC REPORTS, 2020, 10 (01)